EyeOP

Company Overview

Snapshot

Founded in January 2012 by Vadim Shmukler and Nir Israeli, EyeOP operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on advancing its Goldmann applanation tonometer (GAT) product through clinical trials.

Business overview

EyeOP is a Health Tech & Life Sciences company specializing in medical devices for glaucoma diagnosis. The company develops a method for intraocular pressure (IOP) measurement, particularly when patients are lying down, which significantly enhances diagnostic accuracy and facilitates timely treatment for glaucoma. Its core product is a system comprising a modified ophthalmic surgical bed with a slit lamp and headrest, designed to enable IOP measurement using a Goldmann applanation tonometer (GAT). EyeOP also offers an alternative configuration featuring a cart for dual IOP-GAT measurement in both sitting and lying positions, serving the global healthcare market.

Company Intelligence Q&A

What is EyeOP's primary focus?

EyeOP focuses on improving glaucoma diagnosis through a novel method for intraocular pressure (IOP) measurement, particularly for patients in a lying down position.

Who founded EyeOP?

EyeOP was founded by Vadim Shmukler and Nir Israeli in January 2012.

What is the key product developed by EyeOP?

EyeOP's key product is a system that utilizes a modified ophthalmic surgical bed with a slit lamp and headrest to enable IOP measurement using a Goldmann applanation tonometer (GAT).

In which stage of development is EyeOP's product?

EyeOP's product, the Goldmann applanation tonometer (GAT) system, is currently in the Clinical Trial stage.

What problem does EyeOP aim to solve?

EyeOP aims to address the challenge of accurately measuring intraocular pressure (IOP) in patients who are lying down, which significantly improves the diagnostic ability and timely treatment of glaucoma.